{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:54:36Z","timestamp":1792151676145,"version":"4.4.0"},"reference-count":15,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.nephro.2008.04.006","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T09:56:39Z","timestamp":1217584599000},"page":"34-40","source":"Crossref","is-referenced-by-count":15,"title":["Conservation du tube primaire sur le site de dialyse en vue du dosage diff\u00e9r\u00e9 de la PTH\u00a0: quels tubes\u00a0? Quelle temp\u00e9rature\u00a0?"],"prefix":"10.1684","volume":"5","author":[{"given":"Xavier","family":"Parent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Alenabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Souberbielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2008.04.006_bib1","unstructured":"K\/DOQI. Guidelines for the management of renal osteodystrophy. Am J Kidney Dis 2003;42(suppl. 3):S1\u2013S201."},{"key":"10.1016\/j.nephro.2008.04.006_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nephro.2006.11.003","article-title":"Comment atteindre et maintenir les recommandations K\/DOQI sur le m\u00e9tabolisme phosphocalcique chez les patients dialys\u00e9s\u00a0: une strat\u00e9gie efficace","volume":"3","author":"Rottembourg","year":"2007","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2008.04.006_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.04.006_bib4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1373\/clinchem.2006.071589","article-title":"Lack of comparability of intact parathyroid hormone measurement among commercial assays for end-stage renal disease patients: implication for treatment decision","volume":"52","author":"Cantor","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.nephro.2008.04.006_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.ki.5001658","article-title":"The need for reliable serum parathyroid hormone measurement","volume":"70","author":"Urena-Torres","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.04.006_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jcp.2004.022186","article-title":"Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice","volume":"58","author":"Twoney","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.nephro.2008.04.006_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1373\/clinchem.2004.046821","article-title":"Preanalytical influences on DPC Immulite 2000\u2122 intact PTH assays of plasma and serum from dialysis patients","volume":"51","author":"Holmes","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.nephro.2008.04.006_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.ki.5002363","article-title":"Stability of intact parathyroid hormone in samples from haemodialysis patients","volume":"72","author":"Cavalier","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.04.006_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nephro.2007.04.003","article-title":"Parathormone et maladie r\u00e9nale chronique","volume":"3","author":"Bacchetta","year":"2007","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2008.04.006_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1258\/000456303763046166","article-title":"Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone","volume":"40","author":"Anderson","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.nephro.2008.04.006_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/000456329403100513","article-title":"Stability of parathyroid hormone-related protein and parathyroid hormone at room temperature","volume":"31","author":"Levin","year":"1994","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.nephro.2008.04.006_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/clinchem\/48.3.566","article-title":"Preanalytical factors in the measurement of intact parathyroid hormone with the DPC Immulite assay","volume":"48","author":"Glendenning","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.nephro.2008.04.006_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000456320103800516","article-title":"Immulite 2000\u2122 parathyroid hormone assay; stability of parathyroid hormone in EDTA blood kept at room temperature for 48h","volume":"38","author":"Omar","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.nephro.2008.04.006_bib14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/clinchem\/48.5.766","article-title":"Parathyroid hormone is more stable in EDTA plasma than in serum","volume":"48","author":"Glenndenning","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.nephro.2008.04.006_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jcp.2004.022186","article-title":"Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice","volume":"58","author":"Twoney","year":"2005","journal-title":"J Clin Pathol"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725508001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725508001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2008.04.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:20:49Z","timestamp":1741184449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725508001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1769725508001533"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2008.04.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}